FINAL PROGR AM - American Society of Gene & Cell Therapy

20
8th Annual Meeting • June 1 - 5, 2005 • St. Louis
GENERAL MEETING INFORMATION
AMERICAN SOCIETY OF GENE
THERAPY
MISSION AND GOALS
The American Society of Gene Therapy (ASGT) is a
professional non-profit medical and scientific
organization dedicated to the understanding,
development and application of gene and related cell and
nucleic acid therapies and the promotion of professional
and public education in the field.
ASGT is the largest medical professional organization
representing researchers and scientists dedicated to
discovering new gene therapies. ASGT was established in
1996, and has grown to close to 3,000 members from
around the world. ASGT is committed to:
· Promoting Research, Development and Application
· Exchanging Information and Promote Education
Among Professionals and the Public
· Promoting Development of Clinical Translations
The ASGT 8th Annual Meeting will serve as a
comprehensive forum to achieve these goals.
NEEDS
Clinical gene transfer has become more and more
complex due to ongoing developments in the fields of
gene therapy itself, together with bioethics, research
integrity, and financial conflicts, as well as new federal
mandates, regulations and guidelines. Oligonucleotide
Based Therapies, RNAi and Vaccine Therapies will also
be discussed as well as many other topics. This meeting
will provide an educational forum for scientists and
clinicians to expand their knowledge about the broad
developments in these fields.
EDUCATIONAL OBJECTIVES
At the conclusion of the activity, the participant should be
able to:
· Discuss key aspects of the current laboratory and/or
clinical research in gene therapy.
· Demonstrate knowledge of methods being used by
gene therapy researchers and practitioners.
· Describe one or more stimulating new areas of
inquiry in the area of gene therapy.
· Demonstrate familiarity with federal regulations and
guidelines for clinical gene transfer studies.
EDUCATIONAL METHODS AND
MATERIALS
Lectures, Case Presentations, Panel Discussions,
Question and Answer Sessions, Workshops, Audio/Video
Presentations, Abstracts, Posters, Executive Summary.
TARGET AUDIENCE
The target audience includes basic science and
translational researchers, clinical investigators, physicians,
industry executives and scientists, postdoctoral fellows,
graduate students, employees of federal government and
regulatory agencies, and other healthcare professionals
with an interest in the latest advancements in the field of
gene therapy.
EVALUATION METHOD
Evaluation by questionnaire will address program
content, presentation, and possible bias. Please take time
to complete the evaluation forms distributed at each
session you attend. Your input and comments are
essential in planning future educational sessions. When
completed, evaluations can be returned to the ushers
assigned to your session or dropped in the evaluation
collection boxes located throughout America’s Center.
ACCREDITATION/CREDIT
DESIGNATION
This activity has been planned and implemented in
accordance with the Essential Areas and policies of the
Accreditation Council for Continuing Medical Education
through the joint sponsorship of Stanford University
School of Medicine and the American Society of Gene
Therapy. Stanford University School of Medicine is
accredited by the ACCME to provide continuing medical
education for physicians.
Stanford University School of Medicine designates this
educational activity for a maximum of 31 category 1
credits toward the AMA Physician’s Recognition Award.
Each physician should claim only those hours of credit
that he/she actually spent in the activity.
DISCLOSURE
It is the policy of Stanford University that the provider
and faculty/presenters disclose any significant financial or
other relationships with commercial companies whose
products may be discussed in the activity, or the
commercial supporters, if any. Stanford University also
requires that faculty disclose any unlabeled use or
investigational use (not yet approved for any purpose) of
pharmaceutical and medical device products. Specific
disclosure will be made to the participants prior to the
educational activity.
Faculty, topics, program schedule, and credit are subject
to change.
CME CERTIFICATES
CME Certificates will be available at the CME desk for
participants requiring CME credit for this meeting.